Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125651102 | 12565110 | 2 | F | 20160718 | 20160718 | 20160728 | EXP | CZ-APOTEX-2016AP009730 | APOTEX | POLAK P, HUSA P, KERKOVSKY M.. RELAPSING SALMONELLA-SEPSIS IN AN IMMUNOCOMPROMISED HOST.. INTERNI-MEDIC-PRO-PRAXI. 2016;18(1):43-45 | 59.00 | YR | F | Y | 50.00000 | KG | 20160728 | MD | CZ | CZ |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125651102 | 12565110 | 1 | SS | MYCOPHENOLATE MOFETIL APOTEX TABLETY | MYCOPHENOLATE MOFETIL | 1 | Unknown | UNK | U | U | 0 | TABLET | |||||||
| 125651102 | 12565110 | 2 | PS | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | 40 MG/DAY | U | U | 78842 | 40 | MG | ||||||
| 125651102 | 12565110 | 3 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125651102 | 12565110 | 4 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125651102 | 12565110 | 5 | C | CALCIUM | CALCIUM | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125651102 | 12565110 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125651102 | 12565110 | 7 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125651102 | 12565110 | 8 | C | DIHYDROCODEINE | DIHYDROCODEINE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125651102 | 12565110 | 9 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125651102 | 12565110 | 10 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Unknown | UNK | Y | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125651102 | 12565110 | 1 | Immunosuppressant drug therapy |
| 125651102 | 12565110 | 2 | Product used for unknown indication |
| 125651102 | 12565110 | 3 | Immunosuppressant drug therapy |
| 125651102 | 12565110 | 4 | Product used for unknown indication |
| 125651102 | 12565110 | 5 | Product used for unknown indication |
| 125651102 | 12565110 | 6 | Product used for unknown indication |
| 125651102 | 12565110 | 7 | Product used for unknown indication |
| 125651102 | 12565110 | 8 | Product used for unknown indication |
| 125651102 | 12565110 | 9 | Product used for unknown indication |
| 125651102 | 12565110 | 10 | Salmonellosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125651102 | 12565110 | OT |
| 125651102 | 12565110 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125651102 | 12565110 | Diarrhoea | |
| 125651102 | 12565110 | Intervertebral discitis | |
| 125651102 | 12565110 | Psoas abscess | |
| 125651102 | 12565110 | Salmonella sepsis | |
| 125651102 | 12565110 | Salmonellosis | |
| 125651102 | 12565110 | Spinal fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125651102 | 12565110 | 1 | 2014 | 0 | ||
| 125651102 | 12565110 | 3 | 2014 | 0 |